Health Care & Life Sciences » Biotechnology | Argos Therapeutics Inc.

Argos Therapeutics Inc.

Argos Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
Market Cap
$905.19 K
Shares Outstanding
10.59 M
Public Float
9.27 M


4233 Technology Drive
Durham North Carolina 27704
United States
Employees -
Updated 09/14/2018
Argos Therapeutics, Inc. is a biopharmaceutical company, which engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. Its product candidates include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Ralph Steinman on May 8, 1997 and is headquartered in Durham, NC.


View All

Hubert Birner
Jeffrey D. Abbey
President, Chief Executive Officer & Director